Catherine Domenger

579 total citations
12 papers, 412 citations indexed

About

Catherine Domenger is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Catherine Domenger has authored 12 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in Catherine Domenger's work include Diabetes Management and Research (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Pancreatic function and diabetes (5 papers). Catherine Domenger is often cited by papers focused on Diabetes Management and Research (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Pancreatic function and diabetes (5 papers). Catherine Domenger collaborates with scholars based in France, United States and Germany. Catherine Domenger's co-authors include Helen M. Colhoun, Stefano Del Prato, Bertrand Cariou, Francisco J. Tinahones, Lawrence A. Leiter, Rita Samuel, Dirk Müller‐Wieland, Kausik K. Ray, Maja Bujas‐Bobanovic and Robert R. Henry and has published in prestigious journals such as Diabetes Care, Diabetes and Diabetes Obesity and Metabolism.

In The Last Decade

Catherine Domenger

12 papers receiving 403 citations

Peers

Catherine Domenger
Joseph F. Largay United States
S Roze France
C Boelen Netherlands
Martin Harker United Kingdom
L N Sandle United Kingdom
Garry John United Kingdom
Catherine Domenger
Citations per year, relative to Catherine Domenger Catherine Domenger (= 1×) peers Gemma Carreras

Countries citing papers authored by Catherine Domenger

Since Specialization
Citations

This map shows the geographic impact of Catherine Domenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Domenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Domenger more than expected).

Fields of papers citing papers by Catherine Domenger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Domenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Domenger. The network helps show where Catherine Domenger may publish in the future.

Co-authorship network of co-authors of Catherine Domenger

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Domenger. A scholar is included among the top collaborators of Catherine Domenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Domenger. Catherine Domenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Colhoun, Helen M., Lawrence A. Leiter, Dirk Müller‐Wieland, et al.. (2020). Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol. Cardiovascular Diabetology. 19(1). 14–14. 23 indexed citations
2.
Ray, Kausik K., Stefano Del Prato, Dirk Müller‐Wieland, et al.. (2019). Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies. Cardiovascular Diabetology. 18(1). 149–149. 27 indexed citations
3.
Colhoun, Helen M., Lawrence A. Leiter, Dirk Müller‐Wieland, et al.. (2019). 175-OR: Effect of Alirocumab in Individuals with Type 2 Diabetes and High Triglycerides and Low High-Density Lipoprotein Cholesterol. Diabetes. 68(Supplement_1). 1 indexed citations
4.
Ray, Kausik K., Lawrence A. Leiter, Dirk Müller‐Wieland, et al.. (2018). Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial. Diabetes Obesity and Metabolism. 20(6). 1479–1489. 71 indexed citations
5.
Gagliardino, Juan José, Catherine Domenger, Ambady Ramachandran, et al.. (2018). Impact of diabetes education and self-management on the quality of care for people with type 1 diabetes mellitus in the Middle East (the International Diabetes Mellitus Practices Study, IDMPS). Diabetes Research and Clinical Practice. 147. 29–36. 34 indexed citations
6.
Gagliardino, Juan José, Catherine Domenger, Hasan İlkova, et al.. (2018). Diabetes education and health insurance: How they affect the quality of care provided to people with type 1 diabetes in Latin America. Data from the International Diabetes Mellitus Practices Study (IDMPS). Diabetes Research and Clinical Practice. 147. 47–54. 12 indexed citations
7.
Leiter, Lawrence A., Bertrand Cariou, Dirk Müller‐Wieland, et al.. (2017). Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM‐INSULIN randomized trial. Diabetes Obesity and Metabolism. 19(12). 1781–1792. 100 indexed citations
8.
Anderson, Barbara J., Lori M. Laffel, Catherine Domenger, et al.. (2017). Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care. 40(8). 1002–1009. 117 indexed citations
9.
Klonoff, David C., et al.. (2016). Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin. Journal of Diabetes Science and Technology. 11(3). 623–630. 15 indexed citations
10.
Klonoff, David C., et al.. (2015). Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen. Journal of Diabetes Science and Technology. 9(3). 625–631. 6 indexed citations
11.
Phillip, Moshe, Lori M. Laffel, Catherine Domenger, et al.. (2014). Glycaemic Control and Acute Complications in European Children, Adolescents, and Young Adults With Type 1 Diabetes in the Teens Study. 1 indexed citations
12.
Klonoff, David C., et al.. (2010). Evaluation of the JuniorSTAR® Half-unit Insulin Pen in Young People with Type 1 Diabetes – User Perspectives. touchREVIEWS in Endocrinology. 9(2). 82–82. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026